Mission

We incubate companies at the convergence of groundbreaking technologies and innovative science，

bringing transformative medicines and solutions to the global market.

 

 

ABIO-X at a Glance 

ABIO-X, backed by CBC group, will have wholly-owned subsidiaries and invest in certain controlled companies

which will each have its own product portfolio and operations managed by a separate leadership team. A decentralized structure allows focus at the subsidiary level while maintaining support

services from the parent holding company.